Tilray Brands (TLRY) Other Operating Expenses (2019 - 2026)
Tilray Brands' (TLRY) quarterly Other Operating Expenses came in at $34.5 million in Q2 2026, up 2179.65% YoY from $1.5 million in Q2 2025, and up 29173.73% on a QoQ basis from $118000.0 in Q1 2026.
Tilray Brands (TLRY) Other Operating Expenses (2019 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 8 years of Other Operating Expenses data on file, last reported at $34.5 million in Q2 2026.
- Quarterly Other Operating Expenses rose 2179.65% year-over-year to $34.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $49.8 million (up 5465.84% YoY) and the FY2026 annual result came in at $96.2 million, up 10463.9% from the prior year.
- Other Operating Expenses grew to $34.5 million in Q2 2026, from $118000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $34.5 million in Q2 2026 to a low of -$1.7 million in Q2 2025.
- A 5-year average of $3.0 million and a median of $57500.0 in 2022 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2024 — Other Operating Expenses tumbled 253.33% — and 2025, when it jumped 57592.31%.
- Tracing TLRY's Other Operating Expenses over 5 years: stood at $64000.0 in 2022, then tumbled by 64.06% to $23000.0 in 2023, then soared by 2095.65% to $505000.0 in 2024, then slumped by 73.47% to $134000.0 in 2025, then surged by 25678.36% to $34.5 million in 2026.
- The last three Other Operating Expenses figures came in at $34.5 million (Q2 2026), $118000.0 (Q1 2026), and $134000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Tilray Brands | 512.33 Mn | 277.70 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 34.54 Mn |
| Feb 28, 2026 | 118,000.00 |
| Nov 30, 2025 | 134,000.00 |
| Aug 31, 2025 | 15.00 Mn |
| May 31, 2025 | -1.66 Mn |
| Feb 28, 2025 | 202,000.00 |
| Nov 30, 2024 | 505,000.00 |
| Aug 31, 2024 | 26,000.00 |
| May 31, 2024 | 4.20 Mn |
| Feb 29, 2024 | -23,000.00 |
| Nov 30, 2023 | 23,000.00 |
| Aug 31, 2023 | -3,000.00 |
| May 31, 2023 | 46,000.00 |
| Feb 28, 2023 | 15,000.00 |
| Nov 30, 2022 | 64,000.00 |
| Aug 31, 2022 | -77,000.00 |
| May 31, 2022 | 51,000.00 |
| Feb 28, 2022 | 861,000.00 |
| Nov 30, 2021 | 46.51 Mn |
| Aug 31, 2021 | 44.90 Mn |